David A Rawlins

Title: The Innovations of David A Rawlins

Introduction

David A Rawlins is a notable inventor based in Tewin, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing advanced drug delivery systems that enhance the efficacy of pharmaceutical compositions.

Latest Patents

One of his latest patents is titled "Sustained release pharmaceutical compositions in oral dosage form." This invention involves oral dosage forms for neutral, zwitterions, or salts of acidic or basic drugs, designed to provide approximate zero-order release kinetics. The core matrix of the drug is combined with a gelling polymer, and the matrix is coated with a water-permeable but insoluble polymer. Another significant patent is a "Pharmaceutical composition" that comprises a freely flowable powder. This powder includes a porous, high-absorption silica or silicate that has absorbed at least 10% by volume of a liquid, pharmaceutically active composition. This innovation is particularly noteworthy when the liquid composition is a corticoid solution, as it requires the silica or silicate to have a mean particle size of at least 10 µm in diameter.

Career Highlights

Throughout his career, David has worked with prominent companies, including Merck Sharp & Dohme Corporation. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address complex medical challenges.

Collaborations

David has collaborated with several professionals in his field, including Claire J Lovegrove and Anthony John Phillips. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

David A Rawlins is a distinguished inventor whose work in pharmaceutical compositions has led to significant advancements in drug delivery systems. His innovative patents reflect his commitment to improving healthcare through science and technology.